# Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients.

> **NCT04777656** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 120 (estimated)

## Conditions studied

- Crohn's Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Phase1 : CDED/Modulen™IBD® + Maintenance therapy
- **DIETARY_SUPPLEMENT:** Phase2 and 3 :

## Key facts

- **NCT ID:** NCT04777656
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-26
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04777656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04777656, "Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04777656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*